Brind.

The FDA conditionally approved Canalevia-CA1 for CID treatment in dogs, and the company is now seeking partners for global commercialization.

1 report, 1 independent Updated Jul 10

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA CID

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
CID
German company

Nothing else this week.

Related events

The FDA regulates animal drug development programs through its Center for Veterinary Medicine.Aug 25

Coverage

Newest first; wire copies grouped

Jul 10ACCESS NewswireEnrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs Company strategy: In discussions with multiple potential animal health company p